Supplemental arginine and high-dose folate may promote bone health by supporting the activity of endothelial-type nitric oxide synthase in bone

Medical Hypotheses

Volumn 64, Issue 5, 2005, Pages 1030-1033

  McCarty, Mark F ^a,b  

^a Pantox Laboratories   (United States)

^b Nutri Guard Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; SUPEROXIDE; TETRAHYDROBIOPTERIN;

ARTICLE; BONE CELL; BONE DENSITY; BONE MINERALIZATION; CATABOLISM; CELL ACTIVITY; ENDOTHELIUM; ENZYME ACTIVITY; HUMAN; LOADING TEST; MECHANICAL STRESS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OXIDATION; PRIORITY JOURNAL; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

EID: 15244346102     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.10.036     Document Type: Article

References (53)

1. van't Hof R.J., Ralston S.H. Nitric oxide and bone. Immunology. 103:2001;255-261
2. Armour K.E., Armour K.J., Gallagher M.E., Godecke A., Helfrich M.H., Reid D.M., et al. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology. 142:2001;760-766
3. Johnson D.L., McAllister T.N., Frangos J.A. Fluid flow stimulates rapid and continuous release of nitric oxide in osteoblasts. Am. J. Physiol. 271:1996;E205-E208
4. McAllister T.N., Frangos J.A. Steady and transient fluid shear stress stimulate NO release in osteoblasts through distinct biochemical pathways. J. Bone Miner. Res. 14:1999;930-936
5. McAllister T.N., Du T., Frangos J.A. Fluid shear stress stimulates prostaglandin and nitric oxide release in bone marrow-derived preosteoclast-like cells. Biochem. Biophys. Res. Commun. 270:2000;643-648
6. Ehrlich P.J., Lanyon L.E. Mechanical strain and bone cell function: a review. Osteoporos. Int. 13:2002;688-700
7. Das U.N. Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp. Biol. Med. (Maywood.). 227:2002;88-93
8. Armour K.J., 't Hof R.J., Armour K.E., Torbergsen A.C., Del Soldato P., Ralston S.H. Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026). Arthritis. Rheum. 44:2001;2185-2192
9. Lin S.K., Kok S.H., Kuo M.Y., Lee M.S., Wang C.C., Lan W.H., et al. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts. J. Bone. Miner. Res. 18:2003;39-46
10. Gewaltig M.T., Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc. Res. 55:2002;250-260
11. Vallance P., Leone A., Calver A., Collier J., Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 20(Suppl 12):1992;S60-S62
12. Leiper J., Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res. 43:1999;542-548
13. Cooke J.P. Does ADMA cause endothelial dysfunction? Arterioscler. Thromb. Vasc. Biol. 20:2000;2032-2037
14. Cooke J.P., Oka R.K. Atherogenesis and the arginine hypothesis. Curr. Atheroscler. Rep. 3:2001;252-259
15. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 99:1999;3092-3095
16. Stuhlinger M.C., Abbasi F., Chu J.W., Lamendola C., McLaughlin T.L., Cooke J.P., et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 287:2002;1420-1426
17. McCarty MF. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine - an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. Med Hypoth 2004; in press
18. Xiao Z.S., Quarles L.D., Chen Q.Q., Yu Y.H., Qu X.P., Jiang C.H., et al. Effect of asymmetric dimethylarginine on osteoblastic differentiation. Kidney Int. 60:2001;1699-1704
19. Lu R., Hu C.P., Wu X.P., Liao E.Y., Li Y.J. Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats. Comp. Med. 52:2002;224-228
20. Yamaguchi T., Sugimoto T., Yano S., Yamauchi M., Sowa H., Chen Q., et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr. J. 49:2002;211-217
21. Cappuccio F.P., Meilahn E., Zmuda J.M., Cauley J.A. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 354:1999;971-975
22. Orwoll E.S., Bevan L., Phipps K.R. Determinants of bone mineral density in older men. Osteoporos. Int. 11:2000;815-821
23. Miyao M., Morita H., Hosoi T., Kurihara H., Inoue S., Hoshino S., et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif. Tissue. Int. 66:2000;190-194
24. MacGregor G.A., Cappuccio F.P. The kidney and essential hypertension: a link to osteoporosis? J. Hypertens. 11:1993;781-785
25. Visser J.J., Hoekman K. Arginine supplementation in the prevention and treatment of osteoporosis. Med. Hyp. 43:1994;339-342
26. Katusic Z.S. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am. J. Physiol. Heart Circ. Physiol. 281:2001;H981-H986
27. Heller R., Munscher-Paulig F., Grabner R., Till U. L-ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J. Biol. Chem. 274:1999;8254-8260
28. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-felmayer G., Werner E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276:2001;40-47
29. Huang A., Vita J.A., Venema R.C., Keaney J.F.J. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J. Biol. Chem. 275:2000;17399-17406
30. Milstien S., Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 263:1999;681-684
31. Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 99:1997;41-46
32. Maier W., Cosentino F., Lutolf R.B., Fleisch M., Seiler C., Hess O.M., et al. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J. Cardiovasc. Pharmacol. 35:2000;173-178
33. Heitzer T., Krohn K., Albers S., Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia. 43:2000;1435-1438
34. Setoguchi S., Mohri M., Shimokawa H., Takeshita A. Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease. J. Am. Coll. Cardiol. 38:2001;493-498
35. Fukuda Y., Teragawa H., Matsuda K., Yamagata T., Matsuura H., Chayama K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart. 87:2002;264-269
36. Setoguchi S., Hirooka Y., Eshima K., Shimokawa H., Takeshita A. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure. J. Cardiovasc. Pharmacol. 39:2002;363-368
37. Higashi Y., Sasaki S., Nakagawa K., Fukuda Y., Matsuura H., Oshima T., et al. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am. J. Hypertens. 15:2002;326-332
38. Fukuda Y., Teragawa H., Matsuda K., Yamagata T., Matsuura H., Chayama K. Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina. Circ. J. 66:2002;58-62
39. Ueda S., Matsuoka H., Miyazaki H., Usui M., Okuda S., Imaizumi T. Tetrahydrobiopterin restores endothelial function in long-term smokers. J. Am. Coll. Cardiol. 35:2000;71-75
40. Heitzer T., Brockhoff C., Mayer B., Wamholtz A., Mollnau H., Henne S., et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ. Res. 86:2000;E36-E41
41. Verhaar M.C., Stroes E., Rabelink T.J. Folates and cardiovascular disease. Arterioscler. Thromb. Vase. Biol. 22:2002;6-13
42. Stroes E.S., van Faassen E.E., Yo M., Martasek P., Boer P., Govers R., et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ. Res. 86:2000;1129-1134
43. Hyndman M.E., Verma S., Rosenfeld R.J., Anderson T.J., Parsons H.G. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H2167-H2172
44. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., Rabelink T.J. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 97:1998;237-241
45. De Vriese A.S., Van D.V., Blom H.J., Vanhoutte P.M., Verbeke M., Lameire N.H. The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate. Diabetologia. 43:2000;1116-1125
46. Van Etten R.W., De Koning E.J., Verhaar M.C., Gaillard C.A., Rabelink T.J. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia. 45:2002;1004-1010
47. Doshi S.N., McDowell I.F., Moat S.J., Lang D., Newcombe R.G., Kredan M.B., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler. Thromb. Vase. Biol. 21:2001;1196-1202
48. Wilmink H.W., Stroes E.S., Erkelens W.D., Gerritsen W.B., Wever R., Banga J.D., et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler. Thromb. Vase. Biol. 20:2000;185-188
49. Verhaar M.C., Wever R.M., Kastelein J.J., van Loon D., Milstien S., Koomans H.A., et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation. 100:1999;335-338
50. Doshi S.N., McDowell I.F., Moat S.J., Payne N., Durrant H.J., Lewis M.J., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 105:2002;22-26
51. Gori T., Burstein J.M., Ahmed S., Miner S.E., Al-Hesayen A., Kelly S., et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation. 104:2001;1119-1123
52. Yang S., Madyastha P., Bingel S., Ries W., Key L. A new superoxide-generating oxidase in murine osteoclasts. J. Biol. Chem. 276:2001;5452-5458
53. Sontakke A.N., Tare R.S. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin. Chim. Acta. 318:2002;145-148